NCT00078468View on ClinicalTrials.gov

Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment

PHASE2CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

September 30, 2004

Conditions

Colorectal Neoplasms

Interventions

DRUG

PELITREXOL/AG-2037

Trial Locations (4)

10021

Pfizer Investigational Site, New York

20007

Pfizer Investigational Site, Washington D.C.

33612

Pfizer Investigational Site, Tampa

92064

Pfizer Investigational Site, Poway

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT00078468 - Study of the GARFT Inhibitor AG2037 in Patients With Metastatic Colorectal Cancer Who Failed Treatment | Biotech Hunter | Biotech Hunter